retatrutide stomach issues What Does Do? Retatrutide, an experimental weight-loss drug,

May offer cardiovascular protection, with possible reductions in cases of major adverse cardiovascular events (MACE) such as myocardial infarction and stroke in high-risk populations 23

The placebo group gained back nearly 21 pounds while the orforglipron group stayed essentially flat

Another phase II study assessed the safety and efficacy of varying doses of retatrutide, included participants with a BMI of 25 to 50 kg/m 2 and an HbA1c of 7.0% to 10.5% [114]

Compounded semaglutide may be prescribed based on your personal weight loss needs

Read terminology guide What official sources say about retatrutide approval and public-use limits

If GLP-1 medications caused C-cell stimulation in humans like they do in rats, calcitonin levels would rise during treatment